|
rdfs:label
|
"Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B"@en
|
|
schema:description
|
"تجربة سريرية"@ar
"ensayu clínicu"@ast
"assaig clínic"@ca
"clinical trial"@en
"clinical trial"@en-ca
"clinical trial"@en-gb
"clinical trial"@en-us
"klinika studo"@eo
"ensayo clínico"@es
"essai clinique"@fr
"ensaio clínico"@gl
"կլինիկական փորձարկում"@hy
"studio clinico"@it
"治験"@ja
"임상시험"@ko
"klinisch onderzoek"@nl
"ensaio clínico"@pt
"ensaio clínico"@pt-br
"клиническое исследование"@ru
"klinické štúdie"@sk
"клінічне випробування"@uk
"thử nghiệm lâm sàng"@vi
"临床试验"@zh
"临床试验"@zh-hans
"臨床試驗"@zh-hant
|
|
schema:dateModified
|
"2026-03-31T20:24:28+00:00"^^xsd:dateTime
|
|
schema:version
|
2476794061
|
|
wikibase:identifiers
|
1
|
|
wikibase:sitelinks
|
0
|
|
wikibase:statements
|
21
|
|
p:P1132
|
wd:statement/Q64676731-82EFD633-3E50-4A79-A314-5FA84E0CC4CD
|
|
p:P1476
|
wd:statement/Q64676731-11491690-FD87-49D2-9F85-006EB08B2182
|
|
p:P17
|
wd:statement/Q64676731-84D401B6-461F-48C6-877A-D223BB7416BB
|
|
p:P2899
|
wd:statement/Q64676731-45DD59EE-1EBD-4A4A-8CB6-107BBA8BAB2F
|
|
p:P3098
|
wd:statement/Q64676731-AA04791B-DA0D-44CB-80D7-B25990836C11
|
|
p:P31
|
wd:statement/Q64676731-D54FC95B-44B7-4D45-B596-C09BA96A1371
|
|
p:P4844
|
wd:statement/Q64676731-C12FA565-4BC6-4866-AFFC-D4754BF205A7
|
|
p:P580
|
wd:statement/Q64676731-914E1F19-572B-4A17-BFC2-53810DBF3B2E
|
|
p:P582
|
wd:statement/Q64676731-7C629651-82E0-4F41-AD8D-04FDC5665DA6
|
|
p:P6099
|
wd:statement/Q64676731-82A1704C-174F-4603-AC8E-03D6773D264E
|
|
p:P6153
|
wd:statement/Q64676731-730A6948-ACCF-442D-AE41-49163AF6F2EF
|
|
wd:statement/Q64676731-7AE92331-E8C9-458C-BB53-ACAA94C9ABCA
|
|
wd:statement/Q64676731-8479056B-A7AB-4D76-84EB-473C2EC925E0
|
|
wd:statement/Q64676731-ABD9A15D-95CA-4D42-AB8C-ADF8ECE2439B
|
|
wd:statement/Q64676731-E1EBF8C3-9E4D-4B52-9394-E3BEAC3EDD7B
|
|
p:P8363
|
wd:statement/Q64676731-B81C6CDF-EC3F-4834-A412-0D25BD8A697B
|
|
p:P859
|
wd:statement/Q64676731-99659F2D-6339-4FE1-9387-FFE306492F48
|
|
p:P921
|
wd:statement/Q64676731-A2F6AC54-DD93-4BA3-8610-318C31066318
|
|
wd:statement/Q64676731-8FBF0A3C-5D5E-4FE4-B856-2556BD4CEE8E
|
|
wd:statement/Q64676731-D15C7840-99C9-41CB-A87F-45BC5E90A101
|
|
wd:statement/Q64676731-E335D371-C3B9-4C49-AE25-5DCE56936AC7
|
|
wdt:P1132
|
148.0^^xsd:decimal
|
|
wdt:P1476
|
"Entecavir and Peginterferon Alfa-2a Sequential Therapy Versus Peginterferon Alfa-2a Monotherapy for HBeAg Positive Chronic Hepatitis B"@en
|
|
wdt:P17
|
Republika han Tsina
|
|
wdt:P2899
|
18.0^^xsd:decimal
|
|
wdt:P3098
|
"NCT00921180"
|
|
wdt:P31
|
臨床試驗
|
|
wdt:P4844
|
interféron alpha
|
|
wdt:P580
|
"2007-02-01T00:00:00+00:00"^^xsd:dateTime
|
|
wdt:P582
|
"2013-12-01T00:00:00+00:00"^^xsd:dateTime
|
|
wdt:P6099
|
المرحلة الرابعة للتجربة السريرية
|
|
wdt:P6153
|
Det nasjonale universitetssykehuset i Taiwan
|
|
醫療財團法人徐元智先生醫藥基金會亞東紀念醫院
|
|
臺中榮民總醫院
|
|
佛教慈濟醫療財團法人花蓮慈濟醫院
|
|
Prifysgol Cenedlaethol Taiwan
|
|
wdt:P8363
|
estudo intervencional
|
|
wdt:P859
|
Det nasjonale universitetssykehuset i Taiwan
|
|
wdt:P921
|
ހެޕަޓައިޓިސް ބީ
|
|
hepatitis
|
|
ھەوکردنی جگەر ئەی
|
|
Peginterferón alfa-2a
|